In SLE, NET-derived LL37–DNA complexes form immune complexes that activate TLR9 signaling in polyclonal B cells, leading to the expansion of autoreactive memory B cells targeting LL37. The gene discussed is TLR9; the disease is systemic lupus erythematosus.